Artiva Biotherapeutics (ARTV) Other Working Capital Changes (2023 - 2026)
Artiva Biotherapeutics (ARTV) posted quarterly Other Working Capital Changes of -$1.3 million for Q4 2023, up 94.46% quarter-over-quarter from -$23.7 million in Q3 2023.
Powered by 
Analysis
Artiva Biotherapeutics (ARTV) Other Working Capital Changes (2023 - 2026) Analysis & Trends
Artiva Biotherapeutics (ARTV) has reported Other Working Capital Changes for 4 consecutive years, with -$2.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 451.07% year-over-year to -$2.6 million; the TTM figure through Mar 2026 stood at -$1.8 million (down 203.93% YoY), while the FY2025 annual figure was $1.5 million, down 21.93% from the prior year.
- Other Working Capital Changes climbed to -$1.3 million in Q4 2023 per ARTV's latest filing, from -$23.7 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $2.9 million in Q2 2025 and bottomed at -$2.6 million in Q1 2026.
- Historically, Other Working Capital Changes has averaged $129090.9 across 4 years, with a median of -$176000.0 in 2024.
- On a YoY basis, Other Working Capital Changes climbed as much as 1067.57% in 2025 and fell as far as 971.59% in 2025.
- Artiva Biotherapeutics' Other Working Capital Changes stood at -$218000.0 in 2023, then rose by 19.27% to -$176000.0 in 2024, then plunged by 971.59% to -$1.9 million in 2025, then sank by 39.61% to -$2.6 million in 2026.
- Business Quant data shows ARTV's Other Working Capital Changes at -$2.6 million in Q1 2026, -$1.9 million in Q4 2025, and -$194000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Artiva Biotherapeutics | 441.23 Mn | 441.23 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 783,000.00 |
| Jun 30, 2026 | 783,000.00 |
| Mar 31, 2026 | -2.63 Mn |
| Mar 31, 2026 | -2.63 Mn |
| Dec 31, 2025 | -1.89 Mn |
| Dec 31, 2025 | -1.89 Mn |
| Sep 30, 2025 | -194,000.00 |
| Sep 30, 2025 | -194,000.00 |
| Jun 30, 2025 | 2.86 Mn |
| Jun 30, 2025 | 2.86 Mn |
| Mar 31, 2025 | 750,000.00 |
| Mar 31, 2025 | 750,000.00 |
| Dec 31, 2024 | -176,000.00 |
| Dec 31, 2024 | -176,000.00 |
| Sep 30, 2024 | 1.50 Mn |
| Sep 30, 2024 | 1.50 Mn |
| Jun 30, 2024 | -296,000.00 |
| Jun 30, 2024 | -296,000.00 |
| Mar 31, 2024 | 936,000.00 |
| Mar 31, 2024 | 936,000.00 |